Dual-Drug Liposomes Suppress Cervical Cancer and Reduce Systemic Chemotherapy Toxicity in Preclinical Models
Researchers engineered nanoscale liposomes co-loaded with sodium new houttuyfonate and doxorubicin, demonstrating enhanced anti-cervical cancer efficacy alongside substantial reductions in ...

